Powered by Patients
SubjectWell (subjectwell.com) earns a Brand Analyzer score of 71 out of 100, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands, Technology brands. Among 2305 Healthcare brands analyzed, SubjectWell ranks in the 68th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 78/100, Digital Presence 82/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 76/100, AI Discoverability 81/100, Brand Authority 24/100.
SubjectWell is a patient recruitment technology company operating under the tagline 'Powered by Patients.' It serves clinical trial sponsors and CROs through its SubjectWell+ platform and OneView portal, supported by what it describes as the largest patient network. The company positions itself as a leading innovator in clinical trial recruitment, aiming to streamline and transform how patients are identified and enrolled in clinical studies.
| Brand Name | SubjectWell |
|---|---|
| Domain | subjectwell.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Antidote, Medidata, Science 37, Clinipace, Veeva Systems (81/100), PatientPoint |
Moz Domain Authority 34/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #4,219,058 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Powered by Patients" (Meta description too short (3 words). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 5 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, GitHub; no detected presence on X (Twitter), YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
SubjectWell scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
SubjectWell has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #4,219,058 (Tranco), open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 34/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
SubjectWell's main competitors include Antidote, Medidata, Science 37, Clinipace, Veeva Systems (81/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: SubjectWell official site
SubjectWell and Veeva Systems are competitors in Healthcare. Brand Analyzer scores SubjectWell at 71/100 and Veeva Systems at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: SubjectWell official site
Popular alternatives to SubjectWell include Antidote, Medidata, Science 37, Clinipace, Veeva Systems (81/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: SubjectWell official site
SubjectWell offers two primary technology products: the SubjectWell+ platform and the OneView portal. These tools support comprehensive patient recruitment solutions for clinical trials. In addition to these technology offerings, SubjectWell provides access to its patient network - described as the largest of its kind - and an extensive partner network, all designed to support sponsors and CROs in their recruitment efforts.
Sources: SubjectWell official site
SubjectWell has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 42, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: SubjectWell official site
SubjectWell is a healthcare technology company specializing in patient recruitment for clinical trials. It operates under the tagline 'Powered by Patients' and positions itself as a leading innovator in patient recruitment technology. The company provides a robust technology platform, the SubjectWell+ platform, and an OneView portal, and claims to maintain the largest patient network available to clinical trial sponsors and CROs.
Sources: SubjectWell official site
SubjectWell rethinks and streamlines patient recruitment for clinical trials. It connects sponsors and CROs with patients through its technology platform and extensive partner network. By leveraging its SubjectWell+ platform and OneView portal, the company transforms clinical trial recruitment processes, addressing what it describes as the greatest challenges in identifying and enrolling appropriate patients for clinical studies.
Sources: SubjectWell official site
SubjectWell scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: SubjectWell official site
SubjectWell's primary users are clinical trial sponsors, contract research organizations (CROs), and patients seeking to participate in clinical trials. Sponsors and CROs use the platform to streamline and improve their patient recruitment processes, while patients engage with SubjectWell's network to find and connect with appropriate clinical studies.
Sources: SubjectWell official site
SubjectWell can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: SubjectWell official site
SubjectWell is known for operating the largest patient network for clinical trial recruitment and for its innovative SubjectWell+ platform and OneView portal. It is recognized as a leading innovator in patient recruitment technology, serving sponsors and CROs in the clinical research industry. Its comprehensive approach to solving patient recruitment challenges in clinical trials is central to its brand identity.
Sources: SubjectWell official site
SubjectWell's popularity in the clinical trial recruitment space stems from its comprehensive patient recruitment solutions and its claim of maintaining the largest patient network available to sponsors and CROs. Its technology platform, SubjectWell+, and the OneView portal are designed to streamline recruitment processes, addressing significant operational challenges faced by clinical research organizations seeking to enroll patients efficiently.
Sources: SubjectWell official site
Ranked closest to SubjectWell: Simply Connect (71/100), ShiftWizard by HealthStream (71/100), Subscribili (71/100), Sunrise Children's Services (71/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).